Pantoprazole Sodium Tablet, Delayed Release
Product Images NDC 51655-744

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 51655-744). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 744 52 Master Bottle Label Approval Rev A 07 21)

Label for Pantoprazole Sodium delayed-release oral tablets, 20 mg strength, supplied as 30 tablets. The label lists storage instructions and cautions, including keeping out of reach of children and not splitting, chewing, or crushing tablets. The product is labeled Rx only and manufactured by Northwind Pharmaceuticals, repackaged by Northwind Health Company, LLC.*

FDA Label Image

Camberlogo1 (Camberlogo1)

FDA Label Image

Camberlogo2 (Camberlogo2)

FDA Label Image

Structure.jpg (Structure)

Chemical structure of pantoprazole shown with its molecular components including fluorine, sodium ion, methoxy groups, and water of hydration (1.5 H2O). The structure depicts the key functional groups characteristic of pantoprazole sodium.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.